As of 2024-12-15, the Relative Valuation of Mersana Therapeutics Inc (MRSN) is (16.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.15 USD, the upside of Mersana Therapeutics Inc based on Relative Valuation is -855.8%.
The range of the Relative Valuation is (16.65) - (18.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 44.6x | 34.4x |
| Forward P/E multiples | 19.0x - 30.5x | 19.4x |
| Fair Price | (16.65) - (18.41) | (16.25) |
| Upside | -874.3% - -956.4% | -855.8% |
| Date | P/E |
| 2024-11-29 | -3.77 |
| 2024-11-27 | -3.63 |
| 2024-11-26 | -3.59 |
| 2024-11-25 | -3.31 |
| 2024-11-22 | -3.38 |
| 2024-11-21 | -3.28 |
| 2024-11-20 | -3.68 |
| 2024-11-19 | -3.68 |
| 2024-11-18 | -3.49 |
| 2024-11-15 | -3.66 |
| 2024-11-14 | -4.17 |
| 2024-11-13 | -4.35 |
| 2024-11-12 | -3.64 |
| 2024-11-11 | -4.19 |
| 2024-11-08 | -4.25 |
| 2024-11-07 | -4.22 |
| 2024-11-06 | -3.87 |
| 2024-11-05 | -3.33 |
| 2024-11-04 | -3.05 |
| 2024-11-01 | -3.01 |
| 2024-10-31 | -3.00 |
| 2024-10-30 | -3.10 |
| 2024-10-29 | -3.21 |
| 2024-10-28 | -3.38 |
| 2024-10-25 | -3.15 |
| 2024-10-24 | -3.33 |
| 2024-10-23 | -3.41 |
| 2024-10-22 | -3.39 |
| 2024-10-21 | -3.48 |
| 2024-10-18 | -3.48 |
| 2024-10-17 | -3.49 |
| 2024-10-16 | -3.49 |
| 2024-10-15 | -3.53 |
| 2024-10-14 | -3.41 |
| 2024-10-11 | -3.26 |
| 2024-10-10 | -3.15 |
| 2024-10-09 | -3.11 |
| 2024-10-08 | -3.29 |
| 2024-10-07 | -3.24 |
| 2024-10-04 | -3.51 |
| 2024-10-03 | -3.34 |
| 2024-10-02 | -3.38 |
| 2024-10-01 | -3.03 |
| 2024-09-30 | -3.13 |
| 2024-09-27 | -3.06 |
| 2024-09-26 | -3.06 |
| 2024-09-25 | -2.98 |
| 2024-09-24 | -3.12 |
| 2024-09-23 | -3.22 |
| 2024-09-20 | -3.58 |